Francesca Lodi

1.2k total citations
6 papers, 74 citations indexed

About

Francesca Lodi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Francesca Lodi has authored 6 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Francesca Lodi's work include RNA modifications and cancer (1 paper), Diabetes and associated disorders (1 paper) and Single-cell and spatial transcriptomics (1 paper). Francesca Lodi is often cited by papers focused on RNA modifications and cancer (1 paper), Diabetes and associated disorders (1 paper) and Single-cell and spatial transcriptomics (1 paper). Francesca Lodi collaborates with scholars based in Belgium, United States and Netherlands. Francesca Lodi's co-authors include Diether Lambrechts, Thomas Van Brussel, Ayse Bassez, Rogier Schepers, Baki Topal, Vincent Vandecaveye, Junbin Qian, Bram Boeckx, Jeroen Dekervel and Chris Verslype and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and European Urology.

In The Last Decade

Francesca Lodi

5 papers receiving 74 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesca Lodi Belgium	4	28	27	22	21	13	6	74
Yunpeng Gao United States	6	45 1.6×	17 0.6×	14 0.6×	17 0.8×	15 1.2×	9	93
Benoit Fiset Canada	6	29 1.0×	38 1.4×	39 1.8×	10 0.5×	4 0.3×	10	91
Rie Nakamoto-Matsubara United States	4	36 1.3×	23 0.9×	13 0.6×	26 1.2×	6 0.5×	7	75
Jenny Li United States	4	45 1.6×	10 0.4×	32 1.5×	20 1.0×	8 0.6×	7	108
Luis Eduardo Rosa Zucca Brazil	5	31 1.1×	26 1.0×	27 1.2×	12 0.6×	10 0.8×	9	82
Juliana Vélez United States	5	72 2.6×	38 1.4×	16 0.7×	46 2.2×	9 0.7×	8	119
Cori Ann Sherwin United States	2	83 3.0×	17 0.6×	4 0.2×	18 0.9×	10 0.8×	2	100
Bangwei Cao China	3	33 1.2×	28 1.0×	17 0.8×	25 1.2×	7 0.5×	6	76
Helmut Lambertz Germany	4	23 0.8×	81 3.0×	25 1.1×	8 0.4×	8 0.6×	4	99
Natalie J. Kurganovs Australia	6	43 1.5×	23 0.9×	14 0.6×	32 1.5×	3 0.2×	9	93

Countries citing papers authored by Francesca Lodi

Since Specialization

Citations

This map shows the geographic impact of Francesca Lodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Lodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Lodi more than expected).

Fields of papers citing papers by Francesca Lodi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Lodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Lodi. The network helps show where Francesca Lodi may publish in the future.

Co-authorship network of co-authors of Francesca Lodi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Lodi. A scholar is included among the top collaborators of Francesca Lodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Lodi. Francesca Lodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lemaître, Pierre, Francesca Lodi, Niels Vandamme, et al.. (2025). Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes. Journal of Clinical Investigation. 135(23).

2.

Bassez, Ayse, Francesca Lodi, Oscar R. Brouwer, et al.. (2024). Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. European Urology. 86(2). 114–127. 13 indexed citations

3.

Cappuyns, Sarah, Vincent Vandecaveye, Bram Boeckx, et al.. (2023). PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. Nature Communications. 14(1). 7825–7825. 33 indexed citations

4.

Busschaert, Pieter, Siel Olbrecht, Liselore Loverix, et al.. (2022). 2022-RA-1136-ESGO A single-cell map of rare ovarian cancer. International Journal of Gynecological Cancer. 32. A412–A413. 2 indexed citations

5.

Parik, Sweta, Juan Fernández-García, Francesca Lodi, et al.. (2022). GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide. Frontiers in Oncology. 12. 988872–988872. 22 indexed citations

6.

Connor, Kate, David W. Murray, Monika A. Jarzabek, et al.. (2020). Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies. Cancers. 12(12). 3531–3531. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact